NM_000535.7:c.1882C>T
Variant summary
Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS3PP5_Very_Strong
The NM_000535.7(PMS2):c.1882C>T(p.Arg628*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,461,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV001362953: RT-PCR analysis on RNA derived from cultured lymphocytes of patients carrying the variant demonstrated nonsense-mediated RNA decay (van der Klift_2010, 2016).". Synonymous variant affecting the same amino acid position (i.e. R628R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay. The gene PMS2 is included in the ClinGen Criteria Specification Registry.
Frequency
Consequence
NM_000535.7 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | MANE Select | c.1882C>T | p.Arg628* | stop_gained | Exon 11 of 15 | NP_000526.2 | P54278-1 | ||
| PMS2 | c.2068C>T | p.Arg690* | stop_gained | Exon 12 of 16 | NP_001393795.1 | A0A8V8TNX6 | |||
| PMS2 | c.1882C>T | p.Arg628* | stop_gained | Exon 11 of 15 | NP_001308943.1 | A0A8V8TQ50 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | TSL:1 MANE Select | c.1882C>T | p.Arg628* | stop_gained | Exon 11 of 15 | ENSP00000265849.7 | P54278-1 | ||
| PMS2 | TSL:1 | c.804-3892C>T | intron | N/A | ENSP00000371758.4 | P54278-2 | |||
| PMS2 | TSL:1 | n.1678+204C>T | intron | N/A | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251434 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at